Watch List: Digimarc Corporation (NASDAQ:DMRC), Autohome (NYSE:ATHM), Gilead Sciences (NASDAQ:GILD), Comtech Telecommunications Corp. (NASDAQ:CMTL), Heron Therapeutics, Inc. (NASDAQ:HRTX)
Digimarc Corp. (NASDAQ:DMRC) CEO Bruce L. Davis sold 5,000 shares of Digimarc Corp. stock in a transaction dated Friday, August 1st. The stock was sold at an average price of $24.66, for a total transaction of $123,300.00. Following the completion of the sale, the chief executive officer now directly owns 5,000 shares of the company’s stock, valued at approximately $123,300. Digimarc Corporation (NASDAQ:DMRC) belongs to Technology … Continue reading Watch List: Digimarc Corporation (NASDAQ:DMRC), Autohome (NYSE:ATHM), Gilead Sciences (NASDAQ:GILD), Comtech Telecommunications Corp. (NASDAQ:CMTL), Heron Therapeutics, Inc. (NASDAQ:HRTX)
Trader’s Recap: Himax Technologies (NASDAQ:HIMX), Baidu Inc (ADR) (NASDAQ:BIDU), WILC, First Potomac (NYSE:FPO), Cohen & Steers (NYSE:CNS)
On 7 AUG Himax Technologies, Inc. (NASDAQ:HIMX) last released its earnings data on Thursday. The company reported $0.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.14. The company had revenue of $196.40 million for the quarter, compared to the consensus estimate of $194.95 million. During the same quarter in the previous year, the company posted $0.12 earnings per share. The company’s revenue … Continue reading Trader’s Recap: Himax Technologies (NASDAQ:HIMX), Baidu Inc (ADR) (NASDAQ:BIDU), WILC, First Potomac (NYSE:FPO), Cohen & Steers (NYSE:CNS)
Eye Catching Stocks: Ambarella (NASDAQ:AMBA), EMCORE (NASDAQ:EMKR), TheStreet (NASDAQ:TST), Integrated Electrical Services, Inc. (NASDAQ:IESC), Engility Holdings, Inc. (NYSE:EGL)
Ambarella (NASDAQ:AMBA) EVP Didier Legall unloaded 15,000 shares of Ambarella stock in a transaction dated Monday, August 11th. The shares were sold at an average price of $29.01, for a total value of $435,150.00. Ambarella, Inc. (NASDAQ:AMBA) belongs to Technology sector. Its net profit margin is 18.80% and weekly performance is 9.23%. On last trading day company shares ended up $31.83. Ambarella, Inc. (NASDAQ:AMBA) distance from … Continue reading Eye Catching Stocks: Ambarella (NASDAQ:AMBA), EMCORE (NASDAQ:EMKR), TheStreet (NASDAQ:TST), Integrated Electrical Services, Inc. (NASDAQ:IESC), Engility Holdings, Inc. (NYSE:EGL)
Investors Watch List: Peregrine Semiconductor Corporation (NASDAQ:PSMI), Discovery Laboratories Inc. (NASDAQ:DSCO), Data I/O Corp. (NASDAQ:DAIO), Geeknet, Inc. (NASDAQ:GKNT), Adobe Systems Inc. (NASDAQ:ADBE)
On 28 JULY Peregrine Semiconductor Corporation (NASDAQ:PSMI) last released its earnings data on Monday. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.11) by $0.01. The company had revenue of $47.10 million for the quarter, compared to the consensus estimate of $44.13 million. During the same quarter in the previous year, the company posted $0.03 earnings per … Continue reading Investors Watch List: Peregrine Semiconductor Corporation (NASDAQ:PSMI), Discovery Laboratories Inc. (NASDAQ:DSCO), Data I/O Corp. (NASDAQ:DAIO), Geeknet, Inc. (NASDAQ:GKNT), Adobe Systems Inc. (NASDAQ:ADBE)
“The Goldfinch” Helps Hachette Defy Amazon.com, Inc. (NASDAQ:AMZN)’s Attack
With no end in sight for Hachette’s long drawn out pricing battle with Amazon.com, Inc. (NASDAQ:AMZN), Donna Tartt’s ‘The Goldfinch’ might be the silver lining in dark cloud looming over the publisher. Trouble has been brewing in the book world since this May as Amazon and Hachette could not agree how to split the revenues from sales of ebooks. Though many new titles from Hachette … Continue reading “The Goldfinch” Helps Hachette Defy Amazon.com, Inc. (NASDAQ:AMZN)’s Attack
Morning Buzz: PharMerica (NYSE:PMC), Array BioPharma (NASDAQ:ARRY), Mobile Mini (NASDAQ:MINI), Genocea Biosciences, Inc. (NASDAQ:GNCA), Health Care REIT, Inc. (NYSE:HCN)
PharMerica Corporation (NYSE:PMC) reported its financial results for the second quarter and six months ended June 30, 2014. Revenues for the second quarter of 2014 were $448.6 million compared with $430.8 million for the second quarter of 2013. The increase in revenue was primarily the result of the fourth quarter 2013 acquisitions and branded drug price inflation, and was partially offset by previously disclosed bed … Continue reading Morning Buzz: PharMerica (NYSE:PMC), Array BioPharma (NASDAQ:ARRY), Mobile Mini (NASDAQ:MINI), Genocea Biosciences, Inc. (NASDAQ:GNCA), Health Care REIT, Inc. (NYSE:HCN)
